UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura

Alwan, Ferras; Vendramin, Chiara; Budde, Ulrich; Liesner, Ri; Taylor, Alice; Thomas, Mari; Lämmle, Bernhard; (2021) Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura. EJHaem , 2 (2) pp. 188-195. 10.1002/jha2.178. Green open access

[thumbnail of Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura.pdf]
Preview
Text
Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura.pdf - Other

Download (998kB) | Preview

Abstract

Despite clinical remission and normal platelet counts, congenital TTP (cTTP) is associated with non-overt symptoms. Prophylactic ADAMTS13 replacement therapy such as plasma infusion (PI) prevents acute episodes and improves symptomatology. There is no current method to investigate disease severity or monitor the impact of treatment. We utilize a dynamic high shear flow assay to further understand disease pathophysiology and determine the impact of cTTP on symptomatology and therapy, despite normal platelet counts. Whole blood, under high shear, was run over collagen-coated channels, causing platelet adhesion to von Willebrand factor (VWF) multimers. The resulting surface coverage by platelet-VWF thrombus was assessed. The normal range was 6-39% in 50 controls. Twenty-two cTTP patients with normal platelet counts were evaluated. Median pre-treatment surface coverage was 89%, and PI reduced coverage to a median of 44% (p = 0.0005). Patients taking antiplatelets had further reduced coverage when combined with PI and improved non-overt symptoms such as headache, lethargy, and abdominal pain in 100% of patients compared to 74% with PI alone (p = 0.046). We use a dynamic assay to report increased in vitro platelet adhesion and aggregation and additionally demonstrate significantly decreased thrombi following PI, with levels in the normal range levels achieved in patients taking additional antiplatelet therapy.

Type: Article
Title: Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/jha2.178
Publisher version: https://doi.org/10.1002/jha2.178
Language: English
Additional information: © 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: Congenital TTP, prophylaxis, shear flow, upshaw schulman syndrome
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10176864
Downloads since deposit
532Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item